Gix Internet said on November 17 that an Ottonomy autonomous delivery robot has entered service at Sheba Medical Center in Israel, joining an existing fleet of robots from other manufacturers under a single dispatch system. The new robot carries chemotherapy medication, blood and bone marrow between departments, according to GlobeNewswire via The Manila Times.
What makes this deployment different from a typical hospital delivery robot rollout?
Most hospitals that add delivery robots buy a fleet from a single vendor and run it on that vendor's own software. Sheba instead runs its robots, including the new Ottonomy unit, through Gix's deliverz.ai platform, which assigns delivery missions by priority, location and resource availability regardless of which company built the machine. Human couriers are coordinated through the same system. Sheba's Head of Innovation for Human Experience, Operations and Logistics, Michal Kaplansky, put it directly: "The future of hospital logistics automation cannot be dependent on a single robot manufacturer."
Why would a hospital want robots from more than one manufacturer?
Mixing vendors protects a hospital from being locked into one company's pricing, hardware roadmap or support quality. It also lets a hospital match robot capabilities to specific tasks, rather than forcing one machine to handle everything from narrow corridors to time-sensitive blood deliveries. Gix CEO Amir Nardimon argued the real value sits in the coordination layer, not the hardware: "Physical AI creates real value only when robots, people and workflows are orchestrated as one system."
What is actually being delivered, and why does that matter?
Chemotherapy medication and blood and bone marrow products are time-sensitive and often irreplaceable on short notice, so delays or misrouted deliveries carry real clinical risk. Automating those specific routes, rather than general supply runs, signals that Sheba is comfortable trusting autonomous navigation with high-stakes cargo, not just linens or meal trays. This builds on an October 2026 deployment where Gix's robots began handling blood and bone marrow transport at the hospital, and a subsequent order from Sheba to double its robot fleet.
How does this fit into the broader push for hospital automation?
Hospitals worldwide are adding autonomous mobile robots for supply runs, specimen transport and medication delivery to free nursing staff for patient care, a trend already visible in deployments from Germany to South Korea. What's less common is a hospital explicitly designing its system to be vendor-agnostic from the outset rather than discovering the lock-in problem after committing to one manufacturer. If Sheba's multi-vendor model holds up operationally, it offers other hospital systems a blueprint for scaling robot fleets without betting the whole program on one company's roadmap.